Year-End Sale is Live! Find Exclusive Prices on the Best Selling Pharma & MedTech Reports. Check Now!
Nov 29, 2024
The evolving landscape of NSCLC treatment presents significant market opportunities for pharmaceutical companies to secure their place.
Read More...
Nov 20, 2024
Despite decades of research, treatment options are limited in the ARDS market. There are only a few treatments available in the ARDS market. The mainstay of management remains supportive care with mechanical ventilation. Other ARDS treatment options for patients include supplemental oxygen, prone positioning, the u...
Read More...
Nov 20, 2024
As no approved drug in the ARDS market, uptake of emerging therapies is expected to be high. Currently, several assets are in the ARDS pipeline.
Read More...
Nov 20, 2024
Acute respiratory distress syndrome (ARDS) prevalence is increasing drastically owing to certain factors such as pneumonia, COVID-19, sepsis,
Read More...
Nov 08, 2024
It is estimated that the cervical cancer treatment space will experience significant changes during the forecast period of 2024–2034. The future is brighter for patients with cervical cancer. Targeted agents and biomarker-driven therapies hold promise for improved outcomes both as single agents and combinations.
Read More...
Nov 08, 2024
The HPV vaccine protects against several types of HPV that can cause different types of cancers, which mainly include cervical cancer
Read More...
Oct 18, 2024
The dynamics of the schizophrenia treatment market is expected to change in future. Key companies are evaluating lead assets to improve treatment space.
Read More...
Oct 10, 2024
The GBM market size in the 7MM following the launch of a few of many emerging therapies is likely to reach 1,083 million by 2023.
Read More...
Sep 30, 2024
Pompe Disease Therapeutics market is evolving immensely with the active participation of key companies such as Sanofi, Actus, Amicus
Read More...
Aug 23, 2024
Several pharmaceutical companies are developing a gene therapy that will positively impact the Duchenne Muscular Dystrophy Treatment Market
Read More...
Roche’s HER2-Positive Breast Cancer Treatment Franchise
Aug 13, 2024
Transforming Multiple Myeloma Treatment: The Promise of Novel Drug Classes
Jul 24, 2024
Newsletter/Whitepaper